Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 449,137
  • Shares Outstanding, K 273,864
  • Annual Sales, $ 200,520 K
  • Annual Income, $ -306,740 K
  • EBIT $ -296 M
  • EBITDA $ -282 M
  • 60-Month Beta 1.95
  • Price/Sales 2.56
  • Price/Cash Flow N/A
  • Price/Book 0.96

Options Overview Details

View History
  • Implied Volatility 102.95% ( -13.58%)
  • Historical Volatility 86.73%
  • IV Percentile 34%
  • IV Rank 19.62%
  • IV High 199.73% on 08/22/24
  • IV Low 79.34% on 03/27/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 2,696
  • Volume Avg (30-Day) 5,427
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 183,389
  • Open Int (30-Day) 168,260

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.20
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.28
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +25.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5900 +3.14%
on 01/16/25
2.2200 -26.13%
on 01/08/25
-0.3300 (-16.75%)
since 12/17/24
3-Month
1.4900 +10.07%
on 11/19/24
2.7200 -39.71%
on 11/07/24
-0.2600 (-13.68%)
since 10/17/24
52-Week
1.1600 +41.38%
on 07/02/24
7.5000 -78.13%
on 01/26/24
-4.4700 (-73.16%)
since 01/17/24

Most Recent Stories

More News
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics

PACB : 1.6400 (+2.50%)
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue

PACB : 1.6400 (+2.50%)
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing

PACB : 1.6400 (+2.50%)
PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets

PACB : 1.6400 (+2.50%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.

GTLB : 63.02 (-1.84%)
PACB : 1.6400 (+2.50%)
AMZN : 225.94 (+2.39%)
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference

PACB : 1.6400 (+2.50%)
Deciphering Disruption: Inside Cathie Wood's Latest Plays

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

GH : 36.66 (-1.74%)
CRSP : 40.53 (+0.57%)
TSLA : 426.50 (+3.06%)
PACB : 1.6400 (+2.50%)
TTD : 124.42 (+2.96%)
U : 21.77 (+0.09%)
MRNA : 34.06 (+0.89%)
AMZN : 225.94 (+2.39%)
COIN : 295.48 (+4.92%)
SQ : 86.96 (+0.67%)
PLTR : 71.77 (+3.65%)
ARKK : 59.61 (+1.48%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The rock star money manager is starting to roll with the rallying market.

GH : 36.66 (-1.74%)
TTD : 124.42 (+2.96%)
PACB : 1.6400 (+2.50%)
PacBio to Present at Upcoming Investor Conferences

PACB : 1.6400 (+2.50%)
Pacific Biosciences: Q3 Earnings Snapshot

Pacific Biosciences: Q3 Earnings Snapshot

PACB : 1.6400 (+2.50%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 1.7517
2nd Resistance Point 1.7133
1st Resistance Point 1.6767
Last Price 1.6400
1st Support Level 1.6017
2nd Support Level 1.5633
3rd Support Level 1.5267

See More

52-Week High 7.5000
Fibonacci 61.8% 5.0781
Fibonacci 50% 4.3300
Fibonacci 38.2% 3.5819
Last Price 1.6400
52-Week Low 1.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar